An International Survey of the Management of Atrial Fibrillation in Critically Unwell Patients.

OBJECTIVES

To evaluate the current management of new-onset atrial fibrillation and compare differences in practice regionally.

DESIGN

Cross-sectional survey.

SETTING

United States, Canada, United Kingdom, Europe, Australia, and New Zealand.

SUBJECTS

Critical care attending physicians/consultants and fellows.

INTERVENTIONS

None.

MEASUREMENTS AND MAIN RESULTS

A total of 386 surveys were included in our analysis. Rate control was the preferred treatment approach for hemodynamically stable patients (69.1%), and amiodarone was the most used antiarrhythmic medication (70.9%). For hemodynamically unstable patients, a strategy of electrolyte supplementation and antiarrhythmic therapy was most common (54.7%). Physicians responding to the survey distributed by the Society of Critical Care Medicine were more likely to prescribe beta-blockers as a first-line antiarrhythmic medication (38.4%), use more transthoracic echocardiography than respondents from other regions (82.4%), and more likely to refer patients who survive their ICU stay for cardiology follow-up if they had new-onset atrial fibrillation (57.2%). The majority of survey respondents (83.0%) were interested in participating in future studies of atrial fibrillation in critically ill patients.

CONCLUSIONS

Significant variation exists in the management of new-onset atrial fibrillation in critically ill patients, as well as geographic variation. Further research is necessary to inform guidelines in this population and establish if differences in practice impact long-term outcomes.